Does dysregulation of the Notch and wingless/Wnt pathways underlie the pathogenesis of Alzheimer’s disease?

Ray, 1998, Molecular pathogenesis of sporadic and familial forms of Alzheimer’s disease, Mol. Med. Today, 4, 151, 10.1016/S1357-4310(98)01229-5 Mandelkow, 1998, Tau in Alzheimer’s disease, Trends Cell Biol., 8, 425, 10.1016/S0962-8924(98)01368-3 Hanger, 1998, New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer’s disease brain using nanoelectrospray mass spectrometry, J. Neurochem., 71, 2465, 10.1046/j.1471-4159.1998.71062465.x Lovestone, 1994, Alzheimer’s disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells, Curr. Biol., 4, 1077, 10.1016/S0960-9822(00)00246-3 Lovestone, 1997, The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes, Neuroscience, 78, 309 Lovestone, 1999, Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations, Biol. Psychiatry, 45, 995, 10.1016/S0006-3223(98)00183-8 Cohen, 1999, The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction, Philos. Trans. R. Soc. Lond. B. Biol. Sci., 354, 485, 10.1098/rstb.1999.0399 Hong, 1997, Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons, J. Biol. Chem., 272, 19547, 10.1074/jbc.272.31.19547 Dale, 1998, Signal transduction by the Wnt family of ligands, Biochem. J., 329, 209, 10.1042/bj3290209 Cook, 1996, Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C, EMBO J., 15, 4526, 10.1002/j.1460-2075.1996.tb00830.x Doornbos, 1999, Protein kinase Czeta is a negative regulator of protein kinase B activity, J. Biol. Chem., 274, 8589, 10.1074/jbc.274.13.8589 Behrens, 1998, Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β, Science, 280, 596, 10.1126/science.280.5363.596 Hart, 1998, Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β, Curr. Biol., 8, 573, 10.1016/S0960-9822(98)70226-X Smalley, 1999, Interaction of Axin and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription, EMBO J., 18, 2823, 10.1093/emboj/18.10.2823 Artavanis-Tsakonas, 1999, Notch signaling: cell fate control and signal integration in development, Science, 284, 770, 10.1126/science.284.5415.770 De Strooper, 1999, Presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain, Nature, 398, 518, 10.1038/19083 Shen, 1997, Skeletal and CNS defects in Presenilin-1-deficient mice, Cell, 89, 629, 10.1016/S0092-8674(00)80244-5 Song, 1999, Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations, Proc. Natl. Acad. Sci. U. S. A., 96, 6959, 10.1073/pnas.96.12.6959 Steiner, 1999, A loss of function mutation of presenilin-2 interferes with amyloid β-peptide production and Notch signalling, J. Biol. Chem., 40, 28669, 10.1074/jbc.274.40.28669 Wong, 1997, Presenilin 1 is required for Notch1 DII1 expression in the paraxial mesoderm, Nature, 387, 288, 10.1038/387288a0 Axelrod, 1996, Interaction between wingless and notch signaling pathways mediated by dishevelled, Science, 271, 1826, 10.1126/science.271.5257.1826 Levesque, 1999, Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and β-catenin, J. Neurochem., 72, 999, 10.1046/j.1471-4159.1999.0720999.x Stahl, 1999, Direct interaction of Alzheimer’s disease-related presenilin 1 with armadillo protein p0071, J. Biol. Chem., 274, 9141, 10.1074/jbc.274.14.9141 Tanahashi, 1999, Isolation of human delta-catenin and its binding specificity with presenilin 1, Neuroreport, 10, 563, 10.1097/00001756-199902250-00022 Zhou, 1997, Presenilin 1 interaction in the brain with a novel member of the Armadillo family, Neuroreport, 8, 2085, 10.1097/00001756-199705260-00054 Kang, 1999, Presenilin 1 facilitates the constitutive turnover of β-catenin: differential activity of Alzheimer’s disease-linked PS1 mutants in the β-catenin-signaling pathway, J. Neurosci., 19, 4229, 10.1523/JNEUROSCI.19-11-04229.1999 Zhang, 1998, Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis, Nature, 395, 698, 10.1038/27208 Murayama, 1998, Direct association of presenilin-1 with β-catenin, FEBS Lett., 433, 73, 10.1016/S0014-5793(98)00886-2 Weihl, 1999, Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB, J. Neurosci., 19, 5360, 10.1523/JNEUROSCI.19-13-05360.1999 Yu, 1998, The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin, J. Biol. Chem., 273, 16470, 10.1074/jbc.273.26.16470 Ray, 1999, Evidence for a physical interaction between presenilin and Notch, Proc. Natl. Acad. Sci. U. S. A., 96, 3263, 10.1073/pnas.96.6.3263 Nishimura, 1999, Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin, a component of the presenilin protein complex, Nat. Med., 5, 164, 10.1038/5526 Bursztajn, 1998, Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis, J. Neurosci., 18, 9790, 10.1523/JNEUROSCI.18-23-09790.1998 Irving, 1997, Tau phosphorylation in cells transfected with wild-type or an Alzheimer’s disease mutant presenilin 1, Neurosci. Lett., 222, 71, 10.1016/S0304-3940(97)13343-2 Takashima, 1998, Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau, Proc. Natl. Acad. Sci. U. S. A., 95, 9637, 10.1073/pnas.95.16.9637